Acquiring Company
Respighi BidCo
Acquired Company
Recordati S.p.A
ItalyMilanManufacturingDescription
Respighi BidCo, backed by CVC and GBL, reached 74.58 percent of Recordati's share capital after the tender offer closed, exceeding the 66.67 percent minimum. CVC also bought 7.36 percent on the open market. The offer reopens November 3 to 9, 2026, and a merger-based delisting follows if the holding stays below 90 percent.
Who to call at Respighi BidCo, and when
When Respighi BidCo changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Respighi BidCo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Respighi BidCo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Respighi BidCo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Respighi BidCo makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Recordati S.p.A?
Recordati S.p.A was acquired by Respighi BidCo, based in Italy. The deal was reported on October 31, 2026. Respighi BidCo is a bidding vehicle backed by CVC and GBL that launched the tender offer for Recordati S.p.A. It secured a dominant position after the tender offer closed. Respighi BidCo is privately held.
When did Respighi BidCo acquire Recordati S.p.A?
Respighi BidCo's acquisition of Recordati S.p.A was reported on October 31, 2026. Respighi BidCo, backed by CVC and GBL, reached 74.58 percent of Recordati's share capital after the tender offer closed, exceeding the 66.67 percent minimum. CVC also bought 7.36 percent on the open market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Recordati S.p.A do?
Recordati S.p.A. is an Italian specialty pharmaceutical group focused on rare diseases and other therapeutic areas. The company generates most of its revenue from prescription medicines and has a vertically integrated model. It is privately held, operating in Manufacturing, and is based in Milan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.